KINNATE BIOPHARMA INC's ticker is KNTE and the CUSIP is 49705R105. A total of 74 filers reported holding KINNATE BIOPHARMA INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $67,900 | -4.6% | 10,864 | -6.9% | 0.00% | – |
| Q4 2022 | $71,157 | -48.4% | 11,665 | +1.1% | 0.00% | – |
| Q3 2022 | $138,000 | -12.7% | 11,534 | -7.7% | 0.00% | – |
| Q2 2022 | $158,000 | -31.0% | 12,496 | -38.6% | 0.00% | – |
| Q1 2022 | $229,000 | -44.1% | 20,350 | -12.0% | 0.00% | – |
| Q4 2021 | $410,000 | -22.1% | 23,127 | +1.3% | 0.00% | -100.0% |
| Q3 2021 | $526,000 | +20.9% | 22,837 | +22.1% | 0.00% | 0.0% |
| Q2 2021 | $435,000 | -31.5% | 18,707 | -8.2% | 0.00% | 0.0% |
| Q1 2021 | $635,000 | – | 20,385 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 9,671,643 | $384,738,000 | 41.79% |
| Foresite Capital Management V, LLC | 875,001 | $34,808,000 | 25.78% |
| Vida Ventures Advisors, LLC | 2,747,074 | $109,279,000 | 22.43% |
| VR Adviser, LLC | 1,473,014 | $58,596,000 | 8.62% |
| RA Capital Management | 3,593,052 | $142,932,000 | 2.00% |
| Logos Global Management LP | 569,602 | $22,659,000 | 1.94% |
| Boxer Capital, LLC | 1,064,665 | $42,352,000 | 1.36% |
| Orbimed Advisors | 3,847,929 | $153,071,000 | 1.34% |
| HARVARD MANAGEMENT CO INC | 498,001 | $19,810,000 | 1.07% |
| DAFNA Capital Management LLC | 68,121 | $2,710,000 | 0.81% |